The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for Metastatic Breast Cancer
73 locations incl. Chandler
Sponsor: American Society of Clinical Oncology
Sex: All·Age: 65+
Code: NCT06377852·Phase 3·Recruiting·Listed Apr 2024
Penn Medicine - Lancaster General Hospital
Clinical research site in Lancaster, Pennsylvania
Part of Penn Medicine
As of July 2026, 1 paid clinical trial is recruiting at Penn Medicine - Lancaster General Hospital in Lancaster, Pennsylvania. Active studies at this site focus on Metastatic Breast Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Penn Medicine - Lancaster General Hospital (1)
More research sites in Lancaster
- Lancaster General Hospital (12 trials)
- Keystone Urology Specialists (8 trials)
- Lancaster General Hospital - Ann B Barshinger Cancer Institute (7 trials)
- Lancaster General Ann B Barshinger Cancer Institute (5 trials)
- Lancaster General Health (4 trials)
- Penn Medicine Lancaster General Health (4 trials)
- Conestoga Eye (3 trials)
- Amish Research Clinic (2 trials)
- Penn Medicine Lancaster General (2 trials)
- US Digestive Health (2 trials)
Explore more
Paid clinical trials in Lancaster, PA · Pennsylvania clinical trials